NEW YORK,Jan. 16,2025-- ENROAD,a brand dedicated to delivering premium,innovative car rooftop box solutions for modern travelers and adventurers,is excited to announce the global launch of the Nomadix
Jan 17, 2025
SHENZHEN,China,Jan. 16,2025-- Recently,Huawei held the conference on the Top Ten Trends of Data Center Facility 2025. At the conference,Yao Quan,President of Data Center Facility Domain,explainedthe t
Jan 17, 2025
Leveraging Over 30 Years of Global Software Expertise for the Energy Industry CALGARY,AB,Jan. 16,2025-- Peloton,a global leader in energy software solutions,today announced its expansion into the Ren
Jan 17, 2025
KASHGAR,China,Jan. 16,2025-- On January 14th,a significant breakthrough was made in the operation mode of the distribution network. The company introduced the "one-click smooth control" func
Jan 17, 2025
NEW YORK,Jan. 17,2025-- Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company") (NASDAQ: HKPD),a leading provider of over the counter ("OTC&
Jan 17, 2025
Launch of \'Beyond Tennis\': A new generative AI tennis league with AI players and data-driven tournaments
Jan 16, 2025
NPST\'s innovative technology underscores its commitment to advancing digital payment adoption to meet diverse user needs,and its strategic adaptability establishes it as a pivotal player in India\'s
Jan 16, 2025
LOS ANGELES,Jan. 15,2025--Azazie,the leading DTC e-tailer for all things bridal and occasion wear,is thrilled to unveil its highly anticipated 2025 Atelier x Prom Collection. Designed for the modern f
Jan 16, 2025
SAN FRANCISCO andSUZHOU,China,Jan. 16,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua
Jan 16, 2025
Key findings in the 2025 InvestOps report: A new report surveying 200 global buy-side operations leaders reveals that the majority (75%) understand the potential benefits of integrating AI,but need m
Jan 15, 2025
SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch
Jan 15, 2025
Free registration with generous rewards! High winning rate,and professional project guidance throughout the entire process!
Jan 15, 2025

© Voice Of Zimbabwe Privacy Policy Contact us